• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Patricia Coyle, MD, Discusses Diagnostic Tools Utilized in Multiple Sclerosis

Article

In this video, Patricia Coyle, MD, director, MS Comprehensive Care Center, Stony Brook Neurosciences Institute, professor and vice chair of clinical affairs, Department of Neurology, SUNY at Stony Brook, emphasized the need to establish biomarkers for the treatment of multiple sclerosis.

In this video, Patricia Coyle, MD, director, MS Comprehensive Care Center, Stony Brook Neurosciences Institute, professor and vice chair of clinical affairs, Department of Neurology, SUNY at Stony Brook, emphasized the need to establish biomarkers for the treatment of multiple sclerosis. Dr Coyle said that the best biomarkers for disease activity available are in neuroimaging with T1 and T2-based MRI measures. There are also nonconventional techniques used that can image microscopic damage. Dr Coyle notes that these techniques are not used routinely clinically, but expects it will be used more and more.

“There is no single diagnostic test for MS.” “We need even more sensitive disease activity for biomarkers,” said Dr Coyle.

Related Videos
Varsha Tanguturi, MD, MPH, Mass General Hospital
 Khush Kharidia, MD, UT Southwestern
Alexandra M. Trevino, MD, Northwestern Medicine
2 experts in this video
2 experts in this video
Andrew Kuykendall, MD, Moffitt Cancer Center
David J. Maron, MD, FASPC, Stanford University School of Medicine
Karen Vo talks about antibullying campaigns and pediatric patients with derm conditions
Hira Ghani, DO, discusses underdiagnosed skin conditions in children
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.